Jason Edward Pope MD
Pain Medicine
President and CEO Evolve Restorative Center
Join to View Full Profile
220 Concourse BlvdSanta Rosa, CA 95403
Phone+1 844-527-7369
Fax+1 844-847-4943
Dr. Pope is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Pain Medicine, 2009 - 2010
Vanderbilt University Medical CenterResidency, Anesthesiology, 2004 - 2008
Indiana University School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2010 - 2026
WV State Medical License 2012 - 2023
OH State Medical License 2009 - 2022
VA State Medical License 2012 - 2022
TN State Medical License 2006 - 2015
AZ State Medical License 2010 - 2012
American Board of Anesthesiology Anesthesiology- American Board of Anesthesiology Pain Medicine
Clinical Trials
Publications & Presentations
PubMed
- Objective, Same-Day SCS Trials with ECAP-Controlled Closed-Loop Therapy: Depth of Response is Maintained from Trial to 12 months.Jason E Pope, Chau M Vu, Johnathan H Goree, Eric G Cornidez, Drew Trainor
Pain and Therapy. 2026-04-01 - Real-World Spinal Cord Stimulation Utilization and Implant Status: An Analysis of a Novel, Real-Time, Remote Monitoring Database.Jason Pope, Robert M Levy, Christopher Gilligan, Leonardo Kapural, Tim Davis
Neuromodulation. 2025-12-17 - 13 citationsThe Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain.Timothy R Deer, Salim M Hayek, Jay S Grider, Jason E Pope, Shane E Brogan
Neuromodulation. 2025-10-01
Journal Articles
- Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline OptionsTimothy R Deer, Michael C Hanes, Jason E Pope, Pain Medicine
Press Mentions
Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar FusionMarch 10th, 2025- PainTEQ Exceeds 75% Enrollment in Landmark SI Joint Fusion StudyMarch 15th, 2021
- Prospective Study Announced for Sacroiliac Joint Fusion DeviceAugust 10th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
